|
End-of-day quote
Korea S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 14,890.00 KRW | +10.30% |
|
-14.03% | -74.06% |
| 23/07 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 22/12 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A287840 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 15,726.4 | 22,250 | 36,200 |
| Spread/Res. | -5.32% | -33.08% | -58.87% |
| Spread/Supp. | +10.30% | +10.30% | +61.68% |
| Support | 13,500 | 13,500 | 9,209.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A287840 Stock
- Charts IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
